JG
LRMR icon

Jefferies Group’s Larimar Therapeutics LRMR Stock Holding History

Jefferies Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,220
Closed -$32K – 2883
2019
Q2 		$32K Buy
+2,220
New +$59.1K ﹤0.01% 2400
2018
Q2 		– Sell
-1,108
Closed -$99K – 2523
2018
Q1 		$99K Buy
+1,108
New +$93.9K ﹤0.01% 2062
2016
Q2 		– Sell
-1,963
Closed -$157K – 2305
2016
Q1 		$157K Sell
1,963
-1,750
-47% -$138K ﹤0.01% 1895
2015
Q4 		$280K Buy
3,713
+1,736
+88% +$279K ﹤0.01% 1808
2015
Q3 		$758K Buy
1,977
+1,870
+1,748% +$843K ﹤0.01% 1329
2015
Q2 		$45K Buy
+107
New +$44.8K ﹤0.01% 2467

Other funds holding LRMR

AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return